ClassID:

170450

G01N2333/5757 - CPC Classification

Classification description:

Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Hormones Vasoactive intestinal peptide [VIP] or related peptides

Recent Application in this class:
#1
20220289836
2022-09-15

Anti-PACAP antibodies and uses thereof

#2
20220195022
2022-06-23

Polynucleotides encoding monoclonal antibodies binding to human pituitary adenylate cyclase-activating polypeptide type I receptor (PAC1) and methods of making thereof

#3
20210324068
2021-10-21

Screening method for identifying anti-PACAP antibodies or antibody fragments suitable for use in treating or preventing PACAP-associated photophobia or light aversion

#4
20210277106
2021-09-09

Methods of treatment with anti-PACAP antibodies

#5
20210017261
2021-01-21

Methods for treating a headache condition using anti-human PAC1 antibodies or antigen-binding fragments thereof

#6
20200172612
2020-06-04

Anti-PACAP antibodies

#7
20200079847
2020-03-12

Anti-PACAP antibodies

#8
20190270807
2019-09-05

Methods of determining whether anti-PACAP antibodies inhibit PACAP-associated photophobia or light aversion

#9
20190218279
2019-07-18

PAC1 antibodies and uses thereof

#10
20170343561
2017-11-30

Diagnostic and therapeutic methods and products related to anxiety disorders

#11
20160376363
2016-12-29

Methods of determining whether anti-PACAP (adenylate cyclase-activating peptide) antibodies or anti-PACAP antigen binding fragments inhibit PACAP-associated photophobia or light aversion

#12
20160361441
2016-12-15

Use of anti-pacap antibodies and antigen binding fragments thereof for treatment, prevention, or inhibition of photophobia

#13
20160304604
2016-10-20

Anti-PACAP antibodies

#14
20150309050
2015-10-29

Diagnostic and therapeutic methods and products related to anxiety disorders

#15
20120142120
2012-06-07

Vasoactive hormone-based stratification of patients suffering from diseases related to endothelial function/dysfunction

#16
20110008911
2011-01-13

DIAGNOSTIC METHOD FOR DISORDERS USING COPEPTIN

#17
20090311186
2009-12-17

Method for controlling the therapy of patients suffering from cardiac insufficiency by means of in vitro determination of threshold values of vasoactive peptides

#18
20090221009
2009-09-03

Diagnostic method for disorders using copeptin